QQ客服 官方微博 反馈留言

	Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma
	Zhang, Bin; Li, Rui; Chang, Chun-Xiao; Han, Yong; Shi, Sheng-Bin; Tian, Jing
刊名	ONCOTARGETS AND THERAPY
	2016
卷号	9页码:3901-3906
关键词	metastatic esophageal cancer pemetrexed dendritic cells serum miR-143
DOI	10.2147/OTT.S107319
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4695193
专题	山东大学
作者单位	1.Shandong Univ, Shandong Ji Ning Peoples Hosp 1, Dept Med Oncol, Shandong, Peoples R China. 2.[Li, Rui 3.Chang, Chun-Xiao 4.Han, Yong 5.Shi,
推荐引用方式 GB/T 7714	Zhang, Bin,Li, Rui,Chang, Chun-Xiao,et al. Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma[J]. ONCOTARGETS AND THERAPY,2016,9:3901-3906.
APA	Zhang, Bin,Li, Rui,Chang, Chun-Xiao,Han, Yong,Shi, Sheng-Bin,&Tian, Jing.(2016).Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma.ONCOTARGETS AND THERAPY,9,3901-3906.
MLA	Zhang, Bin,et al."Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma".ONCOTARGETS AND THERAPY 9(2016):3901-3906.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。